What is enVVeno Medical Corporation Annual Net Profit?

enVVeno Medical Corporation Annual Net Profit rose 7.22% in the last year to $21.82 M. Its sector's average net profit growth for the last fiscal year was 3.61%.

What is enVVeno Medical Corporation Price to Earning Ratio?

enVVeno Medical Corporation Price to Earning Ratio is -2.29, which is negative.

What is enVVeno Medical Corporation Stock Price?

enVVeno Medical Corporation Stock Price fell 51.69% and underperformed its sector by 58.25% in the past year.

What is enVVeno Medical Corporation Quarterly Net profit?

enVVeno Medical Corporation Quarterly Net profit fell 10.27% YoY to $6.23 M. Its sector's average net profit growth YoY for the quarter was 27.3%.

What is enVVeno Medical Corporation Mutual Fund Holding?

enVVeno Medical Corporation Mutual Fund Holding increased by 0.23% in the last quarter to 8.85.

What is enVVeno Medical Corporation Promoter Share Holding?

enVVeno Medical Corporation Promoter Share Holding increased by 0.58% in the most recent quarter to 2.67%.

What is enVVeno Medical Corporation Institutional Holding?

enVVeno Medical Corporation Institutional Holding decreased by 5.48% in the last quarter to 24.2.

How is the enVVeno Medical Corporation today?

The enVVeno Medical Corporation today is trading in the down by -3.72% at 2.85.

How has enVVeno Medical Corporation performed historically?

The enVVeno Medical Corporation is currently trading down -3.72% on an intraday basis in the past week the index fell -0.35%. The index has been up 4.01% in the past quarter and fell -51.69% in the past year. You can view this in the overview section.

enVVeno Medical Corporation XNAS: NVNO

enVVeno Medical Corporation Live Share Price Today, Share Analysis and Chart

Name: enVVeno Medical Corporation: Is Infosys Ltd. worth buying?
Item: enVVeno Medical Corporation
Rating: 0.93466675
Author: Trendlyne DVM scores

Download real time

2.85 -0.11 (-3.72%)

56.02% Fall from 52W High

86,519 XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)

enVVeno Medical Corporation Key Metrics

My Metrics

Default

Market Capitalization Below industry Median Unavailable in chosen country	50
PE TTM Negative PE TTM Unavailable in chosen country	-2.3
PEG TTM Negative PEG TTM Unavailable in chosen country	-0.3
Price to Book Below industry Median Unavailable in chosen country	1.2
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	24.2
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-10.3
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	7.2
Piotroski Score Low in industry Unavailable in chosen country	1
Rel Perf vs Sector quarter% Unavailable in chosen country	3.2

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

12.7 / 100

Technically Bearish

24.7 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

enVVeno Medical Corporation Stock Price Analysis

Day Price Range -3.7% 1 Day return Unavailable in chosen country	2.8 (LTP) 2.82.9 LowHigh
Week Price Range -0.4% 1 Week return Unavailable in chosen country	2.8 (LTP) 2.83 LowHigh
Month Price Range -18.8% 1 Month return Unavailable in chosen country	2.8 (LTP) 2.63.8 LowHigh
52 Week Price Range -51.7% 1 Year return Unavailable in chosen country	2.8 (LTP) 2.56.5 LowHigh

View full Share Price History

enVVeno Medical Corporation Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

enVVeno Medical Corporation Stock Analysis

enVVeno Medical Corporation stock analysis with key metrics, changes, and trends.

enVVeno Medical Corporation Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$21.82 M	7.22%	positive	Annual Net Profit rose 7.22% in the last year to $21.82 M. Its sector's average net profit growth for the last fiscal year was 3.61%.
Price to Earning Ratio	-2.29	-	negative	Price to Earning Ratio is -2.29, which is negative.
Stock Price	$2.85	-51.69%	negative	Stock Price fell 51.69% and underperformed its sector by 58.25% in the past year.
Quarterly Net profit	$6.23 M	10.27%	negative	Quarterly Net profit fell 10.27% YoY to $6.23 M. Its sector's average net profit growth YoY for the quarter was 27.3%.
Mutual Fund Holding	8.85 %	0.23%	positive	Mutual Fund Holding increased by 0.23% in the last quarter to 8.85.
Promoter Share Holding	2.67 %	0.58%	positive	Promoter Share Holding increased by 0.58% in the most recent quarter to 2.67%.
Institutional Holding	24.20 %	-5.48%	negative	Institutional Holding decreased by 5.48% in the last quarter to 24.2.

VIEW LESS

Loading data..

enVVeno Medical Corporation - Company Profile

What does enVVeno Medical Corporation do?

enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).

2024

Gross Remuneration

Year

enVVeno Medical Corporation Live Share Price Today, Share Analysis and Chart

56.02% Fall from 52W High

enVVeno Medical Corporation Key Metrics

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

enVVeno Medical Corporation Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

enVVeno Medical Corporation Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

enVVeno Medical Corporation Stock Analysis

enVVeno Medical Corporation stock analysis with key metrics, changes, and trends.

Annual Net Profit rose 7.22% in the last year to $21.82 M. Its sector's average net profit growth for the last fiscal year was 3.61%.

Price to Earning Ratio is -2.29, which is negative.

Stock Price fell 51.69% and underperformed its sector by 58.25% in the past year.

Quarterly Net profit fell 10.27% YoY to $6.23 M. Its sector's average net profit growth YoY for the quarter was 27.3%.

Mutual Fund Holding increased by 0.23% in the last quarter to 8.85.

Promoter Share Holding increased by 0.58% in the most recent quarter to 2.67%.

Institutional Holding decreased by 5.48% in the last quarter to 24.2.

enVVeno Medical Corporation - Company Profile

What does enVVeno Medical Corporation do?

enVVeno Medical Corporation Management structure

Mr. Robert A. Berman

Director and Chief Executive Officer

Dr. Marc H. Glickman, M.D.

Senior Vice President and Chief Medical Officer

Dr. Hamed Alavi

Senior Vice President and Chief Technology Officer

Mr. Craig Glynn

Principal Accounting Officer, Chief Financial Officer and Treasurer

enVVeno Medical Corporation Board of directors

Mr. Robert C. Gray

Independent Director

Mr. Matthew M. Jenusaitis

Independent Director

Dr. Sanjay Shrivastava

Independent Director

Dr. Francis Duhay

Independent Director

Mr. Robert A. Berman

Director and Chief Executive Officer

enVVeno Medical Corporation FAQ

How is enVVeno Medical Corporation today?

enVVeno Medical Corporation today is trading in the red, and is down by -3.72% at 2.85.

How has enVVeno Medical Corporation performed historically?

enVVeno Medical Corporation is currently trading down -3.72% on an intraday basis. In the past week the stock fell -0.35%. stock has been up 4.01% in the past quarter and fell -51.69% in the past year. You can view this in the overview section.